Both metformin and resveratrol have promising anticancer effects because they decrease the development of some cancer cell lines in in vitro studies through pathways, including the PI3K-Akt, AMPK-mTOR, and MAPK cascades [12,13,14,15]. Here, AKT1 is linked to cancer.